Covid 19 Research using Clinical Trials (Home Page)
Nutrition supportWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (2)
Correlated MeSH Terms (3)
|
Name (Synonyms) |
Correlation |
D016638 | Critical Illness NIH | 0.14 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
There was an interaction between mortality, nutritional intake and the Nutrition Risk in
Critically ill (NUTRIC) score suggesting that those with higher NUTRIC scores benefited the
most from increasing nutritional intake. Yet limited data were in Chinese patients. The
current outbreak of novel coronavirus, named COVID-19, was first reported from Wuhan, China
on Dec ember 31 , 2019. There are about 16% patients need ICU admission. The objective of
this study is to validation of the "NUTRIC" nutritional risk assessment tool in Chinese ICU
patients diagnosed as COVID-19.
Primary Outcomes
Measure: 28-day all cause mortality Time: from admission to 28-day/discharge, an average of length of ICU stay is 28-day
Secondary Outcomes
Measure: All cause infection Time: from admission to 28-day/discharge, an average of length of ICU stay is 28-day
Measure: The rate of complications Time: from admission to 28-day/discharge, an average of length of ICU stay is 28-day
Measure: Length of ICU stay Time: from admission to 28-day/discharge, an average of length of ICU stay is 28-day
Measure: Duration of mechanical ventilation Time: from admission to 28-day/discharge, an average of length of ICU stay is 28-day
No related HPO nodes (Using clinical trials)